halofantrine has been researched along with debrisoquin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Lennard, MS; Sijumbil, G; Simooya, OO; Tucker, GT | 1 |
1 trial(s) available for halofantrine and debrisoquin
| Article | Year |
|---|---|
Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians.
Topics: Administration, Oral; Adult; Antimalarials; Black People; Chloroquine; Chromatography, Gas; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Humans; Liver; Male; Phenanthrenes; Zambia | 1998 |
2 other study(ies) available for halofantrine and debrisoquin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |